<DOC>
	<DOCNO>NCT01277107</DOCNO>
	<brief_summary>This multi center , double blind placebo control , two-way crossover study patient Insomnia suffer difficulty fall asleep stay asleep . This study intend assess efficacy Zaleplon AP improve sleep parameter , compare placebo .</brief_summary>
	<brief_title>A Polysomnographic Study Compare Efficacy Gastric Retentive Zaleplon Accordion Pill Placebo Subjects With Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zaleplon</mesh_term>
	<criteria>Subjects age 18 65 year age Subjects meet DSM IV diagnostic criterion Primary Insomnia Subjects report time bed ≥6.5 ≤9 hour Subjects report one week sleep diary ( least 3 7 night ) TST ≤6.5 hour Subjects report one week sleep diary ( least 3 7 night ) Wake time sleep &gt; 1.0 hour Subjects report one week sleep diary ( least 3 7 night ) ≥30 minute time sleep onset On two night PSG screen mean WASO ≥60 minute neither night le 45 minute On two night PSG screen mean LPS ≥20 minute neither night le 15 minute On two night PSG screen TST ≤6.5 hour two night Body mass index 18 34 inclusive Subjects report median habitual bedtime 9:00pm ( 21:00 hour ) 12:00am ( 00:00 ) one week sleep diary ( base 3 night ) . Participation another drug clinical trial within 1 month prior first screen diary day ( calculate previous study 's last dosing date ) . On screen PSG night 1 AHI &gt; 10 ( apnea hypopnea index ) On screen PSG night 1 PLMAI ≥10 ( periodic limb movement arousal ) Subject circadian rhythm disorder include shift work need travel ≥3 time zone course study Subject sleep disorder ( e.g . Restless Legs Syndrome ) Use drug know effect sleep wake function within 5 half life drug two week , whichever come first . Subject history ( past year ) alcohol substance abuse Subject need smoke sleep period time Subject report habitual napping ( 3 time per week ) Subject currently significant history seizure , sleep apnea restless leg syndrome sleep disorder , opinion investigator responsible , contraindicate his/her participation Subjects recent history clinically define GERD , peptic ulcer gastrointestinal surgery appendectomy herniotomy , opinion investigator responsible , contraindicate his/her participation Subject gastrointestinal disorder likely influence drug absorption , history inflammatory bowel disease , intestinal obstruction , irritable bowel syndrome , severe gastrointestinal narrowing , frequent nausea emesis , regardless etiology , opinion investigator responsible , contraindicate his/her participation Subjects suffer Axis 1 Psychiatric Disorder opinion investigator responsible may interfere full participation Subject significant history cardiac , pulmonary , hepatic renal disease condition major complication/illness , opinion investigator responsible , contraindicate his/her participation . The subject clinically important abnormal finding determine medical history , physical examination , electrocardiogram , clinical laboratory test , determine investigator Subject take CNSactive drug ( include herbal product CNS effect ) , know affect sleep/wake cycle include limited anxiolytic , hypnotic , antidepressant , sedate H1 antihistamine , systemic steroid , anticonvulsant , narcotic analgesic , respiratory stimulant respiratory decongestant , OTC prescription diet aid , OTC prescription stimulant , St. John 's Wort , melatonin . Females pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>PSG</keyword>
	<keyword>LPS</keyword>
	<keyword>TST</keyword>
	<keyword>WASO</keyword>
	<keyword>Subjects With Insomnia characterize Difficulty Falling Asleep Staying Asleep</keyword>
</DOC>